Estriol 3-glucosiduronate

CAS : 2479-91-6

Ref. 3D-FE176604

Informations sur le produit

• Nom: Estriol 3-glucosiduronate
• Synonymes: β-D-Glucopyranosiduronic acid, (16α,17β)-16,17-dihydroxyestra-1,3,5(10)-trien-3-yl, Estrane, β-D-glucopyranosiduronic acid deriv., Glucopyranosiduronic acid, 16α,17β-dihydroxyestra-1,3,5(10)-trien-3-yl, β-D-, (16α,17β)-16,17-Dihydroxyestra-1,3,5(10)-trien-3-yl β-D-glucopyranosiduronic acid, β-D-Glucosiduronic acid, 16α,17β-dihydroxyestra-1,3,5(10)-trien-3-yl

Description

Estriol 3-glucosiduronate is a form of estriol that is used in the treatment of breast cancer. It is a dry powder that elutes at 3 minutes and has a transport rate of 0.1 cm/min in sephadex g-100. Estriol 3-glucosiduronate can be synthesized by reacting estradiol with glucuronic acid and reacting with triethylamine solution. The molecule has shown to have anti-tumor effects in sarcoma cell lines, as well as being an ATP-dependent transporter.

3DCTKP:
A prodrug that is hydrolyzed in vivo to cefotaxime, its active form, 3-Desacetylcefotaxime potassium (3DCTKP) is an antibacterial agent that belongs to the group of β-lactam antibiotics. It has antagonistic effects against clostridium

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 464.51 g/mol
• Formule: C₂₄H₃₂O₉
• Degré de pureté: Min. 95%